Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Insulin Delivery Devices Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

A08111
Pages: NA
Jun 2021 | 265 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Insulin Delivery Devices Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Request Now !

Insulin a glucose directing hormone, is an essential part of the treatment plan for many patients with advanced type 2 diabetes mellitus (T2DM) and patients with T1DM. Insulin facilitates the diversion of glucose get from the bloodstream to the muscle and adipose tissues to be stored and used as fuel. Insulin cannot be consumed in the form of a tablet or a swallowed in liquid form, as it would be degenerated by the time it reaches bloodstream, by the digestive enzymes and juices. Hence, injection or infusion of insulin is processed into the fatty tissue. Henceforth, a number of devices are in use to deliver insulin to the target location, which include syringes, insulin pumps, insulin pens and jet injectors. Subcutaneous injections is the most common used route of insulin administration. However, no single insulin delivery device works perfectly for everyone. The evaluation of use of a particular delivery device is based on factors like person’s insulin regimen, ability to afford a particular device and its refill supplies, ability to operate a particular device and daily schedule or leisure-time activities.

Insulin-Delivery-Devices

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2019–2027

  Base year considered

  2019

  Forecast period

  2020–2027

  Forecast units

  Value ($)

  Segments covered

  Product types, Distribution channels, End users and Region

  Regions covered

•             North America (U.S., Canada, Mexico)

•             Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•             Asia-Pacific (Japan, China, India, Australia, South Korea, Rest          of Asia-Pacific)

•             LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

Novo Nordisk A/S, Eli Lilly, Sanofi-Aventis, Becton Dickinson and Company, Medtronic PLC, Johnson and Johnson, Biocon Limited, Tandem Diabetes Care Inc., B. Braun Melsungen AG and F. Hoffmann-La Roche.


COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to novel coronavirus
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Recent studies have also highlighted the rising prevalence and infections of Novel coronavirus in diabetic population
  • Regulatory authorities have recommended the diabetic populace to take extra precautions as they are at higher risk of acquiring an infection as compared to the normal populace 
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to insulin delivery devices has been reduced and this segment have to face negligence subsequently causing negative impact on market insulin drug delivery market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

One of the most prominent factor driving the growth of this market is growing diabetic populace, obesity and sedentary lifestyle. In addition to this, innovations in techniques of insulin delivery systems, and healthy reimbursement policies, rising awareness among population about the diabetes control and the accessibility to insulin delivery systems and advancements in human insulin delivery systems are the other factors ensuring growth of the insulin delivery devices market. Injecting insulin is the most common delivery system in insulin administration, it has some backlashes like injection pain, needle phobia, lipodystrophy and peripheral hyperinsulinemia. Hence, the need prevails for an insulin delivery systems capable of delivering insulin non-invasively. Reseach and development to make the noninvasive delivery of insulin are being heavily funded which would create opportunities for industry players introduce innovative products into market, thereby boosting the insulin delivery devices market growth. 

Despite the widespread of diabetic conditions in the populace affecting millions across the globe, pharmaceutical firms, scientists and researchers haven’t yet succeeded in discovering a cure for the diabetes. The absence of an efficient, adequate and effective cure for diabetes, the betterment of insulin therapy is emphasized on. Thus, the quest for innovative solutions for better treatment and insulin delivery measures is in progress and highlights positive impact on the overall market for insulin delivery device. Also, it is anticipated that rising incidences of hyperglycemia, developing self-injectable devices, and rising support by FDA endorsements fuel the insulin delivery devices market growth. 

However, availability of oral insulin as an alternative medication to injected insulin delivery technique and high cost of insulin delivery systems are would potentially hamper the market development of insulin delivery devices. In addition, lack of accessibility to public healthcare and associated high cost in Latin America and stringent regulations and product approvals in the Middle East would constrain the growth of insulin delivery systems.

Growing prevalence of diabetic conditions to drive the market growth

Surging number of diabetic populace due to aging, obesity, and sedentary lifestyles are the factors contributing to this market. Obesity is one of the major drivers of the market resulting into development of diabetes in populace. Over 1.9 billion people allover were categorized as overweight, with around 600 million people in them were obese. Obesity and overweight conditions are the risk factors, highly linked to the incidence of diabetes, which is rising by tremendous growth, thus risking massive rise cases diabetes, according to stats by WHO.  According to the International Diabetes Federation, diabetic population worldwide, is anticipated to hit the 500 million mark by 2030. The rise in diabetic conditions would surge the demand for insulin delivery devices thus fueling the growth of this insulin delivery devices market.  

Technological advancements and product launches to fuel the growth

Novo Nordisk introduced HumaPen Memoir, a pen device with features such as recording time and date of previous injections, to ease the tedious efforts and reduce errors enabling better memory function by providing accurate data. With developments in continuous glucose monitors (CGM), the integrated use of CGM with insulin pumps has revolutionized the insulin delivery devices development. Recently developed CGM products have shown better results in comparison with the older ones and offer precise results with better glycemic control in T1DM patients. Recently, Bigfoot Biomedical in partnership with Eli Lilly, developed solutions for enhanced delivery and dosing of insulin with the integration of artificial intelligence. The partnership aims in launching a portfolio of innovative products related to diabetes management in the insulin delivery devices market.

Novo Nordisk in February 2019, collaborated with Abbott to offer digital solutions for diabetic patients using insulin pens. This partnership aims at enhanced diabetes management by giving access to healthcare professionals and diabetic patients to generate optimized and productive outcomes. Thus, technological advancements in insulin delivery system and novel product launches would offer immense opportunities to industry players over the coming years.  

Key segments:

Segments

Sub-segments

  Product type

 

  • Insulin syringes
  • Insulin pens
  • Insulin pumps
  • Insulin injectors

  Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

  End users

  • Hospitals/Nursing homes
  • Patient/home care centers
  • Diabetic care centers
  • Other

 

 

Key benefits of the report:

  • This study presents the analytical depiction of the global insulin delivery devices industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global insulin delivery devices market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global insulin delivery devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the insulin delivery devices market.
  • The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Insulin Delivery Devices Market research report:

  • Who are the leading market players active in the insulin delivery devices market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

 

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Insulin Delivery Devices Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers